New epilepsy drug tested in kids for first time

NCT ID NCT04903314

Completed Knowledge-focused Sponsor: SK Life Science, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a medicine called cenobamate in 26 children with partial-onset seizures. The goal was to see how the drug moves through the body and if it is safe. The study did not aim to cure or control seizures long-term, but to gather important information for future use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARTIAL EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

focal epilepsy visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARTIAL EPILEPSY

Contacts and locations

Locations

Ajou University Hospital

Suwon, South Korea
Chungbuk National University Hospital

Cheonju, South Korea
Cincinnati Children's Hospital

Cincinnati, Ohio, 45229, United States
Duke University

Durham, North Carolina, 27705, United States
I. Sz. Gyermekgyógyászati Klinika

Budapest, Hungary
Le Bonheur Children's Hospital

Memphis, Tennessee, 38103, United States
Mid-Atlantic Epilepsy and Sleep Center

Bethesda, Maryland, 20817, United States
Missouri University Pediatric and Adolescent Specialty Clinic

Columbia, Missouri, 65201, United States
MultiCare Institute - Mary Bridge Children's Neurology

Tacoma, Washington, 98405, United States
Northeast Regional Epilepsy Group

Hackensack, New Jersey, 07601, United States
Phoenix Children's Hospital

Phoenix, Arizona, 85016, United States
Seoul National University Hospital

Seoul, South Korea
Severance Hospital

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.